Resource Center
This e-book presents a synopsis of how we operate, our services, and most importantly, our commitment to you and your patients. Viracor provides accurate results, exceptional turnaround times, and personalized guidance that puts you at the forefront of empowering the patient's healthcare decisions.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.